---
figid: PMC6297758__MMR-19-01-0345-g08
figtitle: Involvement of c-myb and E2F1 in the expression and amplification of MYCN
organisms:
- Mus musculus
- Cricetulus griseus
- Homo sapiens
- Bos taurus
- Escherichia coli
- Drosophila melanogaster
pmcid: PMC6297758
filename: MMR-19-01-0345-g08.jpg
figlink: /pmc/articles/PMC6297758/figure/f7-mmr-19-01-0345/
number: F7
caption: Involvement of c-myb and E2F1 in the expression and amplification of MYCN.
  (A) Model mechanism indicates the possible contribution of c-myb and E2F1 genes
  in the apoptotic elimination of MYCN-amplified neuroblastoma (MNA NB) cells via
  the upregulation of MYCN expression. MYCN overexpression indirectly activates the
  E2F1-induced apoptosis signaling pathway, potentially by inhibiting miR-20a and
  miR-92a, which prevent upregulation of E2F genes. (B) Flow schema showing the alterations
  in MYCN gene copy number and expression of c-myb, E2F1 and potential target genes
  following treatment with c-myb RNAi in MYCN-amplified neuroblastoma cell lines.
  *Spearman's correlation coefficient, two-tailed (rs=1.0, P<0.01). miR, microRNA;
  RNAi, RNA interference. c-myb, transcriptional activator myb; MYCN, MYCN proto-oncogene
  bHLH transcription factor; E2F1, E2F transcription factor 1; p-73, tumor protein
  p73; p21, cyclin-dependent kinase inhibitor 1A; L3MBTL1, L3MBTL1 histone methyl-lysine
  binding protein; B-myb, MYB proto-oncogene like 2; hCdt1, chromatin licensing and
  DNA replication factor 1; Rb, RB transcriptional corepressor; GMNN, geminin.
papertitle: MYCN is amplified during S phase, and c-myb is involved in controlling
  MYCN expression and amplification in MYCN-amplified neuroblastoma cell lines.
reftext: Nevim Aygun, et al. Mol Med Rep. 2019 Jan;19(1):345-361.
year: '2019'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9293835
figid_alias: PMC6297758__F7
figtype: Figure
organisms_ner:
- Bos taurus
- Cricetulus griseus
- Mus musculus
- Homo sapiens
- Drosophila melanogaster
redirect_from: /figures/PMC6297758__F7
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6297758__MMR-19-01-0345-g08.html
  '@type': Dataset
  description: Involvement of c-myb and E2F1 in the expression and amplification of
    MYCN. (A) Model mechanism indicates the possible contribution of c-myb and E2F1
    genes in the apoptotic elimination of MYCN-amplified neuroblastoma (MNA NB) cells
    via the upregulation of MYCN expression. MYCN overexpression indirectly activates
    the E2F1-induced apoptosis signaling pathway, potentially by inhibiting miR-20a
    and miR-92a, which prevent upregulation of E2F genes. (B) Flow schema showing
    the alterations in MYCN gene copy number and expression of c-myb, E2F1 and potential
    target genes following treatment with c-myb RNAi in MYCN-amplified neuroblastoma
    cell lines. *Spearman's correlation coefficient, two-tailed (rs=1.0, P<0.01).
    miR, microRNA; RNAi, RNA interference. c-myb, transcriptional activator myb; MYCN,
    MYCN proto-oncogene bHLH transcription factor; E2F1, E2F transcription factor
    1; p-73, tumor protein p73; p21, cyclin-dependent kinase inhibitor 1A; L3MBTL1,
    L3MBTL1 histone methyl-lysine binding protein; B-myb, MYB proto-oncogene like
    2; hCdt1, chromatin licensing and DNA replication factor 1; Rb, RB transcriptional
    corepressor; GMNN, geminin.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - MYB
  - MYCN
  - E2F1
  - CDKN1A
  - L3MBTL1
  - MYBL2
  - GMNN
  - Myb
  - Mycn
  - E2f1
  - L3mbtl1
  - Gmnn
  - Cdkn1a
  - Nsg1
  - Tpt1
  - Tceal1
  - Gabrg2
  - UBE2L3
  - TCEAL1
  - NSG1
  - H3P16
  - WARS1
  - Mybl2
  - N-b
  - dap
  - LanB2
  - anon-70Db
  - rb
  - anon-70Dc
---
